Clinical Trial Update: Effects of HFNC on Moderate and Severe Respiratory Failure Patients [NA]

View source ↗

Summary

A clinical trial update about high-flow nasal cannula therapy in moderate to severe respiratory failure, with the current trial status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Failure

Drugs mentioned

• High-Flow Nasal Cannula (HFNC) Therapy

Snippet

Sponsor: Southeast University, China | Conditions: Respiratory Failure | NA | Status: UNKNOWN